Bluebook
Diagnostics and Tools Blue Book October 2024
2024 - October: Report on M&A and financing activity in the diagnostics and tools industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Nusano closed a $115MM Series A Financing, led by Verily Life Sciences, Section 32, Wasatch Venture Partners, and American Cancer Society’s BrightEdge
- Vizgen closed a $150.3MM Series A Financing, led by Arch Venture Partners, Tao Capital Partners, and Northpond Ventures
- Cytovale closed a $100MM Series A Financing, led by Breakout Ventures, Canada Pension Plan Investment Board, Sands Capital Management, Breakout Ventures, and Global Health Investment Corporation